Lash Care APS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.5% 6.2% 9.6% 10.2% 17.9%  
Credit score (0-100)  20 38 24 23 8  
Credit rating  B BB B B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  861 0 0 0 0  
Gross profit  267 0.0 371 428 375  
EBITDA  1.6 10.5 15.0 12.5 -72.9  
EBIT  1.6 5.2 11.0 12.5 -84.8  
Pre-tax profit (PTP)  1.0 3.6 9.3 11.1 -84.8  
Net earnings  0.8 2.8 7.2 8.7 -66.2  
Pre-tax profit without non-rec. items  1.0 3.6 9.3 11.1 -84.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 15.9 11.9 11.9 0.0  
Shareholders equity total  50.8 53.6 60.8 69.5 3.4  
Interest-bearing liabilities  84.1 84.1 84.1 0.0 0.0  
Balance sheet total (assets)  353 517 400 335 363  

Net Debt  -59.6 -157 -120 -55.3 -51.1  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  861 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  267 0.0 371 428 375  
Gross profit growth  0.0% -100.0% 0.0% 15.4% -12.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  353 517 400 335 363  
Balance sheet change%  0.0% 46.3% -22.6% -16.3% 8.2%  
Added value  1.6 10.5 15.0 16.5 -72.9  
Added value %  0.2% 0.0% 0.0% 0.0% 0.0%  
Investments  0 11 -8 0 -24  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.2% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.2% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.6% 0.0% 3.0% 2.9% -22.6%  
Net Earnings %  0.1% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.1% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.1% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.5% 1.2% 2.4% 3.4% -24.3%  
ROI %  1.2% 3.8% 7.8% 11.7% -232.7%  
ROE %  1.6% 5.3% 12.6% 13.4% -181.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  14.4% 10.4% 15.2% 20.8% 0.9%  
Relative indebtedness %  35.2% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  18.5% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -3,650.0% -1,501.8% -796.0% -442.1% 70.1%  
Gearing %  165.5% 156.9% 138.3% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.4% 1.9% 2.1% 3.2% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 0.6 0.8 0.2 0.2  
Current Ratio  1.4 1.2 1.3 1.0 0.9  
Cash and cash equivalent  143.7 241.4 203.7 55.3 51.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  126.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  35.9% 0.0% 0.0% 0.0% 0.0%  
Net working capital  90.2 77.1 88.3 12.9 -41.4  
Net working capital %  10.5% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0